Regulation of gene expression in hepatic cells by the mammalian target of rapamycin (mTOR)

PLoS ONE

Volumn 5, Issue 2, 2010, Pages

  Jimenez, Rosa H ^a   Lee, Ju Seog ^b   Francesconi, Mirko ^c   Castellani, Gastone ^c   Neretti, Nicola ^a,d   Sanders, Jennifer A ^a   Sedivy, John ^d   Gruppuso, Philip A ^a  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; RAPAMYCIN; RNA; IMMUNOSUPPRESSIVE AGENT; MYC PROTEIN; PROTEIN SERINE THREONINE KINASE; SIGNAL PEPTIDE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL GROWTH; CELL PROLIFERATION; CLUSTER ANALYSIS; CONTROLLED STUDY; E BOX ELEMENT; FIBROBLAST; GENE CONTROL; GENE EXPRESSION; LIVER CELL; MICROARRAY ANALYSIS; NONHUMAN; ONCOGENE C MYC; PROMOTER REGION; RAT; ANIMAL; CELL LINE; CELL TRANSFORMATION; DRUG EFFECT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM;

MAMMALIA;

ANIMALS; BINDING SITES; CELL LINE; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; CLUSTER ANALYSIS; FIBROBLASTS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEPATOCYTES; IMMUNOSUPPRESSIVE AGENTS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-MYC; RATS; SIROLIMUS; TRANSCRIPTION FACTORS;

EID: 77949347378     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009084     Document Type: Article

References (45)

1. Hall MN (2008) mTOR-what does it do? Transplant Proc 40: S5-S8.
2. Polak P, Hall MN (2009) mTOR and the control of whole body metabolism. Curr Opin Cell Biol 21: 209-218.
3. Sabatini DM (2006) mTOR and cancer: insights into a complex relationship. Nat Rev Cancer 6: 729-734.
4. Guertin DA, Sabatini DM (2007) Defining the role of mTOR in cancer. Cancer Cell 12: 9-22.
5. Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, et al. (2009) Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460: 392-395.
6. James MJ, Zomerdijk JC (2004) Phosphatidylinositol 3-kinase and mTOR signaling pathways regulate RNA polymerase I transcription in response to IGF-1 and nutrients. J Biol Chem 279: 8911-8918.
7. Erbay E, Park IH, Nuzzi PD, Schoenherr CJ, Chen J (2003) IGF-II transcription in skeletal myogenesis is controlled by mTOR and nutrients. J Cell Biol 163: 931-936.
8. Mayer C, Zhao J, Yuan X, Grummt I (2004) mTOR-dependent activation of the transcription factor TIF-IA links rRNA synthesis to nutrient availability. Genes Dev 18: 423-434.
9. Cunningham JT, Rodgers JT, Arlow DH, Vazquez F, Mootha VK, et al. (2007) mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. Nature 450: 736-740.
10. Abraham RT (2002) Identification of TOR signaling complexes: More TORC for the cell growth engine. Cell 111: 9-12.
11. Loewith R, Jacinto E, Wullschleger S, Lorberg A, Crespo JL, et al. (2002) Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Mol Cell 10: 457-468.
12. Dever TE (2002) Gene-specific regulation by general translation factors. Cell 108: 545-556.
13. Wullschleger S, Loewith R, Hall MN (2006) TOR signaling in growth and metabolism. Cell 124: 471-484.
14. Raught B, Gingras AC, Sonenberg N (2001) The target of rapamycin (TOR) proteins. Proc Natl Acad Sci U S A 98: 7037-7044.
15. Xie MW, Jin F, Hwang H, Hwang S, Anand V, et al. (2005) Insights into TOR function and rapamycin response: chemical genomic profiling by using a highdensity cell array method. Proc Natl Acad Sci U S A 102: 7215-7220.
16. Gstaiger M, Luke B, Hess D, Oakeley EJ, Wirbelauer C, et al. (2003) Control of nutrient-sensitive transcription programs by the unconventional prefoldin URI. Science 302: 1208-1212.
17. Grewal SS, Evans JR, Edgar BA (2007) Drosophila TIF-IA is required for ribosome synthesis and cell growth and is regulated by the TOR pathway. J Cell Biol 179: 1105-1113.
18. Jimenez RH, Boylan JM, Lee JS, Francesconi M, Castellani G, et al. (2009) Rapamycin response in tumorigenic and non-tumorigenic hepatic cell lines. PLoS ONE 4: e7373.
19. Tsao MS, Smith JD, Nelson KG, Grisham JW (1984) A diploid epithelial cell line from normal adult rat liver with phenotypic properties of 'oval' cells. Exp Cell Res 154: 38-52.
20. Lee LW, Tsao MS, Grisham JW, Smith GJ (1989) Emergence of neoplastic transformants spontaneously or after exposure to N-methyl-N'-nitro-N- nitrosoguanidine in populations of rat liver epithelial cells cultured under selective and nonselective conditions. Am J Pathol 135: 63-71.
21. Mateyak MK, Obaya AJ, Adachi S, Sedivy JM (1997) Phenotypes of c-Mycdeficient rat fibroblasts isolated by targeted homologous recombination. Cell Growth Differ 8: 1039-1048.
22. Aerts S, Van Loo P, Thijs G, Mayer H, de Martin R, et al. (2005) TOUCAN 2: the all-inclusive open source workbench for regulatory sequence analysis. Nucleic Acids Res 33: W393-W396.
23. Veerla S, Hoglund M (2006) Analysis of promoter regions of co-expressed genes identified by microarray analysis. BMC Bioinformatics 7: 384.
24. Morrish F, Neretti N, Sedivy JM, Hockenbery DM (2008) The oncogene c-Myc coordinates regulation of metabolic networks to enable rapid cell cycle entry. Cell Cycle 7: 1054-1066.
25. Kim J, Lee JH, Iyer VR (2008) Global identification of Myc target genes reveals its direct role in mitochondrial biogenesis and its E-box usage in vivo. PLoS ONE 3: e1798.
26. Hochberg Y, Benjamini Y (1990) More powerful procedures for multiple significance testing. Stat Med 9: 811-818.
27. Francesconi M, Remondini D, Neretti N, Sedivy JM, Cooper LN, et al. (2008) Reconstructing networks of pathways via significance analysis of their intersections. BMC Bioinformatics 9 Suppl 4: S9.
28. Edgar R, Domrachev M, Lash AE (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30: 207-210.
29. Sanders JA, Gruppuso PA (2005) Coordinated Regulation of c-Myc and Max in Rat Liver Development. Am J Physiol Gastrointest Liver Physiol 290: G145-G155.
30. Cortes SM, Rodriguez FV, Sanchez PI, Perona R (2008) The role of the NFkappaB signalling pathway in cancer. Clin Transl Oncol 10: 143-147.
31. Ephrussi A, Church GM, Tonegawa S, Gilbert W (1985) B lineage - specific interactions of an immunoglobulin enhancer with cellular factors in vivo. Science 227: 134-140.
32. Sen R, Baltimore D (1986) Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46: 705-716.
33. Hay N, Sonenberg N (2004) Upstream and downstream of mTOR. Genes Dev 18: 1926-1945.
34. Eilers M, Eisenman RN (2008) Myc's broad reach. Genes Dev 22: 2755-2766.
35. Prouty SM, Hanson KD, Boyle AL, Brown JR, Shichiri M, et al. (1993) A cell culture model system for genetic analyses of the cell cycle by targeted homologous recombination. Oncogene 8: 899-907.
36. Greasley PJ, Bonnard C, Amati B (2000) Myc induces the nucleolin and BN51 genes: possible implications in ribosome biogenesis. Nucleic Acids Res 28: 446-453.
37. Hulf T, Bellosta P, Furrer M, Steiger D, Svensson D, et al. (2005) Wholegenome analysis reveals a strong positional bias of conserved dMyc-dependent E-boxes. Mol Cell Biol 25: 3401-3410.
38. Shaw RJ, Cantley LC (2006) Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 441: 424-430.
39. Buller CL, Loberg RD, Fan MH, Zhu Q, Park JL, et al. (2008) A GSK-3/TSC2/mTOR pathway regulates glucose uptake and GLUT1 glucose transporter expression. Am J Physiol Cell Physiol 295: C836-C843.
40. Fingar DC, Blenis J (2004) Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene 23: 3151-3171.
41. Ikezoe T, Nishioka C, Bandobashi K, Yang Y, Kuwayama Y, et al. (2007) Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells. Leuk Res 31: 673-682.
42. Murooka TT, Rahbar R, Fish EN (2009) CCL5 promotes proliferation of MCF-7 cells through mTOR-dependent mRNA translation. Biochem Biophys Res Commun 387: 381-386.
43. Ravitz MJ, Chen L, Lynch M, Schmidt EV (2007) c-myc Repression of TSC2 contributes to control of translation initiation and Myc-induced transformation. Cancer Res 67: 11209-11217.
44. Schmidt EV, Ravitz MJ, Chen L, Lynch M (2009) Growth controls connect: interactions between c-myc and the tuberous sclerosis complex-mTOR pathway. Cell Cycle 8: 1344-1351.
45. Balakumaran BS, Porrello A, Hsu DS, Glover W, Foye A, et al. (2009) MYC activity mitigates response to rapamycin in prostate cancer through eukaryotic initiation factor 4E-binding protein 1-mediated inhibition of autophagy. Cancer Res 69: 7803-7810.